Men+Tdap+HPV Placebo+Tdap+HPV Total
  n=402 n=399 N=801
Age (Yrs) 11.9 ± 1.7 11.8 ± 1.5 11.9 ± 1.6
Sex      
Male 233 (58%) 244 (61%) 477 (60%)
Female 169 (42%) 155 (39%) 324 (40%)
Race      
Asian 5 (1%) 7 (2%) 12 (1%)
Black, Non-Hispanic 39 (10%) 36 (9%) 75 (9%)
White, Non-Hispanic 319 (79%) 310 (78%) 629 (79%)
Native American/Alaskan 1 (<1%) 2 (<1%) 3 (<1%)
Pacific/Hawaii 0 2 (<1%) 2 (<1%)
Other 38 (9%) 42 (11%) 80 (10%)
Weight (kg): 50.4 ± 15.7
(n=400)
50.6 ± 15.3
(n=398)
50.5 ± 15.5
(n=798)
Height (cm): 153.3 ± 11.7
(n=400)
152.9 ± 11.3
(n=398)
153.1 ± 11.5
(n=798)
Body Mass Index: 21.1 ± 4.7
(n=400)
21.4 ± 5.0
(n=398)
21.2 ± 4.8
(n=798)
Table 1: Demographics of enrolled study participants